Part D: Patients must have measurable disease for Part D Patients must have measurable disease Measurable disease Re-registration: measurable disease Measurable disease Patients must have measurable disease Patients must have measurable disease Documented metastatic disease (may be measurable or non-measurable) Subjects must have measurable disease. Measurable disease Subjects with measurable disease. Patients may have either non-measurable disease OR measurable disease Have measurable disease Patients must have at least one measurable site of disease Measurable disease or non-measurable disease and refractory to or intolerant of existing therapies (Part 1) Measurable disease Part B: Patients must have measurable disease Patients who do not have measurable disease on MRI Measurable disease Presence of measurable disease. Measurable metastatic disease. Patients must have measurable disease Measurable disease Patients must have measurable disease Phase 1: patients may have measurable or non-measurable disease; measurable disease via RECIST 1.1 is required for Phase 2 patients Measurable disease Subjects must have measurable disease Patients must have measurable disease. Measurable disease Measurable disease Patients must have measurable disease Must have measurable disease defined by: Measurable disease Subjects must have measurable disease Measurable disease Measurable disease in at least one site Presence of measurable disease: Measurable disease Subjects with measurable or non-measurable lesions. PHASE I: Patients may have measurable or non-measurable disease Non-measurable disease only Patients who have no measurable disease Measurable disease or non measurable disease bone lesions in the absence of measurable disease as per RECIST 1.1 Measurable disease Measurable disease Measurable disease; Measurable disease Measurable disease. Measurable disease Measurable or non-measurable metastatic disease Patient has measurable disease. Patients must have at least one site of measurable disease Measurable disease Measurable disease Measurable disease Patients must have measurable disease Measurable disease Measurable disease Measurable disease Measurable disease required Patients must have measurable disease Measurable disease Measurable disease Has measurable disease Measurable disease Patients must have either measurable or evaluable limited-stage DLBCL \r\n* Patients rendered free of measurable or evaluable disease by virtue of biopsy (resection) are also eligible; NOTE: if patient has measurable disease it must be documented on the Lymphoma Baseline Tumor Assessment Form\r\n* All measurable disease must be assessed within 28 days prior to registration\r\n* Patients with non-measurable disease with or without measurable disease must have all non-measurable disease assessed within 42 days prior to registration Patients must have measurable disease Has measurable disease Subjects must have measurable disease Subjects must have measurable disease Measurable disease at time of enrollment Measurable disease Has measurable disease. Measurable disease at screening Must have measurable disease Patient must have measurable disease or detectable (non-measurable) disease: Measurable disease will be defined by RECIST 1.1. Measurable disease criteria: Measurable disease Measurable or non-measurable disease will be allowed, but only those with measurable disease will be evaluable for the response rate endpoint Measurable disease Measurable disease Patients must have measurable disease Participant has measurable and/or non-measurable disease Measurable disease, requiring treatment Both measurable as well as non-measurable disease will be allowed Measurable disease Patients must have measurable disease Measurable disease Measurable disease: measurable by gadolinium MRI scan Measurable or non-measurable disease Measurable disease Measurable disease Measurable disease Measurable or non-measurable disease Non-measurable or measurable disease Measurable disease; note: disease that is measurable by physical examination only is not eligible The patient has measurable disease Measurable and non-measurable disease will be allowed Patients must have measurable disease Patients must have measurable disease at baseline Measurable disease at the time of enrollment Measurable disease Patients may have measurable or non-measurable disease. x-rays and/or scans for disease assessment of measurable disease must have been completed within 28 days prior to registration; non-measurable disease must also be assessed within 28 days prior to registration; (expansion – patients must have measurable disease) Patients may have measurable or non-measurable disease; x-rays and/or scans for disease assessment of measurable disease must have been completed within 28 days prior to registration; non-measurable disease must also be assessed within 28 days prior to registration Measurable disease Patients must have measurable disease, defined as at least one tumor that is measurable Measurable or non-measurable disease will be allowed Subjects must have measurable disease Measurable disease Patients must have measurable disease: Presence of measurable disease Both measurable and non-measurable disease are allowed Measurable disease Measurable or non-measurable disease Have measurable disease. Measurable disease Measurable disease; Patients with measurable and non-measurable disease are eligible. Patients may or may not have cancer-related symptoms. Participants do not need to have measurable disease; most patients will not have measurable disease at the time of treatment Presence of measurable disease Measurable disease Patients must have disease that can be evaluated radiographically; this may be measurable disease or non-measurable disease; measurable disease is defined as that which can be measured in at least one dimension as >= 20 mm with conventional techniques, or >= 10 mm by high resolution imaging; disease that is identified on radiology studies, but does not meet the criteria for measurable disease, is considered non-measurable Measurable disease At least 1 measurable site of disease Measurable disease. Must have measurable disease defined as: Must have measurable disease for Part A, measurable disease or non-measurable disease for Part B Measurable or non-measurable disease will be allowed Measurable tumor Non-measurable or measurable, metastatic disease Patients must have measurable disease Patients may have either non-measurable disease OR measurable disease Measurable disease Measurable or non-measurable disease Measurable disease Measurable disease Only evidence of disease is non-measurable. Measurable or non-measurable disease Patients must have measurable disease May have measurable disease, non-measurable disease, or both. Measurable disease Measurable disease Measurable or non-measurable disease that has progressed since last treatment. Measurable disease Measurable disease Measurable or non-measurable disease Patients must have measurable disease (Phase I) Measurable disease Patients must have measurable disease Presence of measurable or non-measurable disease. Measurable disease Disease may be measurable or non-measurable Measurable disease At least one site of measurable disease Measurable disease Subjects must have measurable disease Measurable disease. Patients who only have non-measurable disease Measurable Disease: Measurable or non-measurable disease will be allowed The participant has measurable or non-measurable disease. Presence of measurable disease Confirmed measurable disease